In this Product Explainer, A/Prof Michael Woodward AM, Geriatrician, outlines NIP eligibility criteria and provides practical guidance on recombinant, adjuvanted RSV vaccination, administration and co-administration in older adults (5 mins).

This educational video was developed by Healthed in collaboration with and with funding from GSK.
Views of the speaker are their own and do not necessarily reflect that of GSK. GSK recommends usage in accordance with the Product Information.

Abbreviations: NIP; National Immunisation Program; RSV, respiratory syncytial virus.

PM-AU-RSA-WCNT-260011. Date of approval: May 2026.